Sheba at Sixty
www.sheba.co.il
Home page | Hospital Map | עברית | RU
Home page > Research and Development > The Research Center of Leukemia and Childhood Malignancies
The Talpiot Medical Leadership Program
SCRC- The Sheba Cancer Research Center
The Research Center of Leukemia and Childhood Malignancies
JSNC - The Joseph Sagol Neuroscience Center
The Amalia Biron Research Institute of Thrombosis and Hemostasis
Pediatric Stem Cell Research Institute
The Sheba Center for Regenerative Medicine, Stem Cell and Tissue Engineering
Innovative Cell replacement therapy for diabetes
AIDS Laboratory, Infectious Diseases Unit
The Infectious Diseases Research Laboratory
Heller Institute of Medical Research
The Gertner Institute for Health Policy and Epidemiology
Publications by Sheba Medical Center staff
Advanced Technologies
Research Programs
Websites
Research Staff
Publications
About The Research
Group members
Publications
Research Staff
Publications
Useful Links
LAB MATES & PROTOCOLS
Popular Science
Research and Development
The Research Center of Leukemia and Childhood Malignancies

 

 

 New Discoveries

 

Children are 30% of our society but 100% of our future

 

 

 

 

Click on photo's to enlarge

 

 

Cancer is the leading cause of death from disease in children. Leukemias and hematopoietic malignancies are the most common types of cancer in children. Although mortality rates for these malignancies have declined significantly, the cure involves intensive and toxic chemotherapy. Our ultimate goal is to cure all children with leukemia and cancer with personalized adjustment of therapy to the severity of the disease and to the molecular genetic abnormalities in the cancer cells. A prerequisite for the achievement of this goal is better understanding of how children get leukemia and what are the differences between normal and cancer cells. This can be realistically achieved by translational research utilizing modern sophisticated genetic and biochemical tools.


The advantage of our location within Sheba medical center is the proximity to the patients and to the most advanced state- of-the-art research infrastructure. Thus questions that arise from observations in patients can be rapidly translated into laboratory research. Similarly laboratory findings can be translated into improvement in patient care. Our affiliation with Tel-Aviv University medical school and the cooperation with Bar-Ilan University and the Weizmann institute of sciences ensure the outstanding academic levels.


 

 

contact us

Prof. Shai Izraeli

 

Head of the section of functional genomics and childhood leukemia and cancer research and a member of the Dpt of Pediatric Hemato-Oncology at the Sheba Medical Center.

 

Associate Professor of Pediatrics at Sackler Medical School, Tel - Aviv University and the genetic department in TAU .

 

Trained in Pediatric Hemato-Oncology and molecular leukemia research in the National Cancer Institute, NIH, Bethesda USA.

Israeli Board certified in Pediatrics and Pediatric Hemato-Oncology.

Co-Chair of the Israeli National Study of childhood acute lymphoblastic leukemia and chair of the Biology and Diagnosis committee of the international BFM study group of childhood hematological malignancies.

 

 

Major research interest on the molecular biology of childhood leukemia. Author of over 80 peer reviewed publications

 

pubmed publication list

 

sizraeli@sheba.health.gov.il

 

 

To Prof. Izraeli Hebrew Web-Page 

 

Terms of Use  |  Contact Us  |  Other Sheba Sites